Skip navigation
logo
(AFX UK Focus) 2008-02-14 07:14
Sanofi-Aventis gets license from Denmark's Statens Serum to develop TB vaccine
Article layout: raw

PARIS (Thomson Financial) - Drugs giant Sanofi-Aventis said its vaccines unit, Sanofi Pasteur, has been licensed by Danish company Statens Serum Institut to develop and sell a new vaccine against tuberculosis.

Financial details were not disclosed, but vaccines unit CEO Wayne Pisano called the agreement "a milestone for Sanofi Pasteur". tfn.paris@thomson.com mjs/ak

COPYRIGHT

Copyright Thomson Financial News Limited 2007. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.

Joint ventures
Production or sales statistics
Article layout: raw
Jump back to site navigation